1618644-29-3

Basic information

• Product Name: Alogliptin Related Compound 23
• Synonyms: Alogliptin Related Compound 23
• CAS NO: 1618644-29-3
• Molecular Formula: C20H13ClN4O2
• Molecular Weight: 376.8
• Mol File: 1618644-29-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 568.7±60.0 °C(Predicted)
• Appearance: /
• Density: 1.45±0.1 g/cm3(Predicted)
• PKA: -3.90±0.40(Predicted)
• CAS DataBase Reference: Alogliptin Related Compound 23(CAS DataBase Reference)
• NIST Chemistry Reference: Alogliptin Related Compound 23(1618644-29-3)
• EPA Substance Registry System: Alogliptin Related Compound 23(1618644-29-3)

Safety Data

• Hazardous Substances Data: 1618644-29-3(Hazardous Substances Data)

Usage

Description

Alogliptin Related Compound 23, also known as N,N’-Bis(2’-cyanobenzyl)-6-chloro-2,4-dioxopyrimidine, is an impurity found in alogliptin (A575425). Alogliptin is an oral antihyperglycemic agent that acts as a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). Alogliptin Related Compound 23 plays a role in the development and production of antidiabetic agents.

Uses

Used in Pharmaceutical Industry:
Alogliptin Related Compound 23 is used as an impurity in the development and production of alogliptin, an oral antihyperglycemic agent. Its presence is crucial for the synthesis and formulation of antidiabetic drugs, as it contributes to the overall effectiveness and safety of the final product.
Alogliptin Related Compound 23 is used as a selective inhibitor of DPP-4 for the management of type 2 diabetes. By inhibiting this enzyme, it helps to increase the levels of insulin and decrease the levels of glucose in the blood, thus providing better control over blood sugar levels.
Additionally, Alogliptin Related Compound 23 may be used in research and development for the discovery of new antidiabetic agents, as understanding the properties and interactions of such compounds can lead to the creation of more effective and safer treatments for diabetes.